ArticleMolecular diversity2026
Advancing the development of deep learning and machine learning models for oral drugs through diverse descriptor classes: a focus on pharmacokinetic parameters (Vdss and PPB).
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the present study, we report a predictive deep learning (DL) and machine learning (ML) model for pharmacokinetics (PK) parameters such as volume of distribution (Vdss) and plasma protein Binding (PPB). Using DL & ML algorithms our study provides a deeper and novel insights into the role of molecular descriptors in determining the PK parameters such as Vdss and PPB. FDA approved drugs with oral route of administration and having reported PK parameters were taken as the dataset. This was used for establishment of the foundational datasets followed by computation of different molecular descriptor classes. Feature engineering by Boruta algorithm exhibited significant increase in accuracy of the models. Features identified by Boruta algorithm, were trained for different models separately for both Vdss and PPB. The highest predictive scores amongst the models were achieved in gradient boosting (GB) and Stacking Classifier with 80% and 78% for Vdss. In the case of PPB, random forest and GB algorithm predicted the highest scores of 73% and 71%, respectively, in comparison to all other algorithms. In summary we report here appropriate ML algorithms like Stacking Classifier-by utilizing an unreported feature engineering algorithm -to predict Vdss and PPB individually considering over 67 descriptors each with ≥ 80% accuracy and 73% accuracy, respectively. Additionally, we developed models based on the shared descriptors between Vdss and PPB. Quantum chemical descriptors like MLFERs (MLFER_BH, MLFER_BO & MLFER_E) and topological descriptors like piPC5, piPC6, piPC9 & TpiPC identified as the common drivers of the functional activity of Vdss and PPB together.
Indexed as
Identifiers
40498231What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.